The chemokine receptor antagonist TAK-779 attenuates atherogenesis

被引：0
|
作者：
van Wanroolj, EJA
Happe, H
de Vos, P
Fujiwara, H
Berkel, THJC
Kulper, J
机构：
[1] LACDR, Leiden, Netherlands
[2] Grad Sch Med, Osaka, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
665
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] TAK-779 - Anti-HIV - Chemokine CCR5 antagonist
    不详
    DRUGS OF THE FUTURE, 2001, 26 (03) : 315 - 317
  • [2] TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice
    Takami, S
    Minami, M
    Katayama, T
    Nagata, I
    Namura, S
    Satoh, M
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (07): : 780 - 784
  • [3] HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice
    van Wanrooij, EJA
    Happé, H
    Hauer, AD
    de Vos, P
    Imanishi, T
    Fujiwara, H
    van Berkel, TJC
    Kuiper, J
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) : 2642 - 2647
  • [4] A chemokine receptor antagonist, TAK-779, and cyclosporin A synergistically prolongs survival of fully MHC-mismatched cardiac allografts in mice.
    Miura, M
    Shimoda, N
    Morita, K
    Watarai, Y
    Fujiwara, H
    Nonomura, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 180 - 180
  • [5] The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
    Ni, Jia
    Zhu, Yi-Na
    Zhong, Xiang-Gen
    Ding, Yu
    Hou, Li-Fei
    Tong, Xian-Kun
    Tang, Wei
    Ono, Shiro
    Yang, Yi-Fu
    Zuo, Jian-Ping
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (08) : 2046 - 2056
  • [6] A ring expansion strategy in antiviral synthesis: A novel approach to TAK-779
    Smalley, TL
    SYNTHETIC COMMUNICATIONS, 2004, 34 (11) : 1973 - 1980
  • [7] A small molecule CCR5 antagonist, TAK-779 exacerbates trinitrobenzene sulfonic acid (TNBS)-induced colitis
    Itoh, J
    Kikuchi, H
    Tanaka, M
    Fukuda, S
    Munakata, A
    GASTROENTEROLOGY, 2004, 126 (04) : A286 - A286
  • [8] CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779
    Nedjai, Belinda
    Viney, Jonathan M.
    Li, Hubert
    Hull, Caroline
    Anderson, Caroline A.
    Horie, Tomoki
    Horuk, Richard
    Vaidehi, Nagarajan
    Pease, James E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (07) : 1822 - 1833
  • [9] Synthesis of Thiophene-Based TAK-779 Analogues by C-H Arylation
    Junker, Anna
    Yamaguchi, Junichiro
    Itami, Kenichiro
    Wuensch, Bernhard
    JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (11): : 5579 - 5586
  • [10] Effects of Blocking the Chemokine Receptors, CCR5 and CXCR3, With TAK-779 in a Rat Small Intestinal Transplantation Model
    Xu, Hengjie
    Firdawes, Sabere
    Yamamoto, Aki
    Zhao, Yu
    Ihara, Yoshiyuki
    Uehara, Shuichiro
    Matsunami, Katsuyoshi
    Otsuka, Hideaki
    Fukuzawa, Masahiro
    Miyagawa, Shuji
    TRANSPLANTATION, 2008, 86 (12) : 1810 - 1817
12345